Bibliographic Source(s)
Academy of Ambulatory Foot and Ankle Surgery. Heel spur syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2003. 6 p. [14 references] |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Academy of Ambulatory Foot and Ankle Surgery. Heel spur syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 12 p.
The guideline is reviewed and updated twice a year as needed (in May and October). According to the guideline developer, this guideline has been reviewed and is still considered current as of September 2009. This review involved new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.
UMLS Concepts ( what's this?)
Click to view all guideline(s) indexed with these concepts
ICD9CM:
Calcaneal spur (726.73); Diagnostic interview and evaluation, not otherwise specified (89.05); Electromyography (93.08); Fasciotomy (83.14); Fracture, cause unspecified (E887); General physical examination (89.7); Gout, unspecified (274.9); Neurologic examination (89.13); Range of motion testing (93.05); Reflex sympathetic dystrophy, unspecified (337.20); Reflex sympathetic dystrophy, unspecified (337.21); Tarsal tunnel syndrome (355.5); Unspecified osteomyelitis, site unspecified (730.20)
MSH:
Adrenal Cortex Hormones; Analgesics; Anesthetics, Local; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases; Bursitis; Electromyography; Fasciitis, Plantar; Foot Deformities, Acquired; Fractures, Bone; Gout; Heel Spur; Immobilization; Medical History Taking; Neoplasms; Neuritis; Neurologic Examination; Neuroma; Orthotic Devices; Osteochondritis; Osteomyelitis; Palpation; Periostitis; Physical Examination; Physical Therapy Specialty; Reflex Sympathetic Dystrophy; Tarsal Tunnel Syndrome
MTH:
Analgesics; Anti-Inflammatory Agents; Antibiotics; Application of strapping; Bone Diseases; Bursitis; Capsulotomy of midfoot with tendon lengthening; Division of Dupuytren's contracture of foot; Electromyography; Fracture; Gout; History taking; Local Anesthetics; Neoplasms; Nerve conduction study; Neuritis; Neurologic Examination; Orthotic Devices; Osteochondritis; Osteomyelitis; Osteotomy of calcaneus; Palpation; physical examination; Physical Therapy (Specialty); Reflex Sympathetic Dystrophy; Release of tendon (procedure); roentgenographic
SNOMEDCT:
Acquired pes (111260007); Analgesic (373265006); Analgesic (53009005); Anti-inflammatory agent (330901000); Anti-inflammatory agent (373283003); Antibiotic (255631004); Arthritis (3723001); Bursitis (84017003); Calcaneal spur (55260003); Capsulotomy of midfoot with tendon lengthening (8096008); Complex regional pain syndrome, type I (128079007); Complex regional pain syndrome, type I (2103002); Corticoid preparation (21568003); Corticoid preparation (79440004); Disorder of bone (76069003); Division of Dupuytren's contracture of foot (282071005); Division of fascia (13885002); Electromyography (42803009); Excision of osteochondroma (392032009); Excision of osteochondroma (392033004); Extracorporeal shockwave lithotripsy (44345001); Fracture (125605004); Fracture (72704001); Gout (90560007); History taking (84100007); Immobilization - action (257884004); Local anesthetic (27548001); Local anesthetic (373477003); Neoplasm (108369006); Nerve conduction study (164721007); Nerve conduction study (51110005); Neuritis (128192007); Neuritis (84299009); Neurological assessment (225398001); Neurological assessment (84728005); Neuroma (25169009); Neuroma (274089002); Neuroma (443892003); Non-steroidal anti-inflammatory agent (16403005); Non-steroidal anti-inflammatory agent (372665008); Orthotic device (224898003); Osteochondritis (70736000); Osteomyelitis (60168000); Osteotomy of calcaneus (133868006); Osteotomy of calcaneus (57561004); Palpation (113011001); Palpation (129434008); Periostitis (41910004); Physical assessment (302199004); Physical assessment (5880005); Physical assessment (81375008); Plantar fasciitis (202882003); Range of motion testing (69212005); Release of tendon (122484000); Strapping procedure (118481004); Tarsal tunnel syndrome (47374004); Vascular insufficiency (86341008)
UMD:
Analyzers, Physiologic, Neuromuscular Function, Gait (16-334); Orthoses (12-837)
Hide...
|
Guideline Category
Diagnosis
Treatment
Clinical Specialty
Podiatry
Intended Users
Podiatrists
Guideline Objective(s)
To provide recommendations for the diagnosis and treatment of heel spur syndrome
Target Population
Patients with heel spur syndrome
Interventions and Practices Considered
Diagnosis
- History, including an evaluation of the chief complaint (nature, location, duration, onset, course, anything that improves or exacerbates symptoms, any previous treatment)and past medical history (allergies/medications, medical history, surgical history, family history, social history)
- Physical examination, including peripheral vascular, neurological, and orthopedic [palpation (direct/lateral pressure), biomechanical/gait analysis, range of motion]
- Diagnostic procedures, including radiographic examination, laboratory tests, additional tests (nerve conduction studies, electromyography, noninvasive vascular testing)
Treatment
- Nonsurgical treatment, including padding and strapping (taping), orthotics, heel cup, shoe modifications, oral anti-inflammatory medications (NSAIDs), anti-inflammatory injectables (i.e., corticosteroids), injection of local anesthetics (i.e., peripheral nerve block), analgesics, physical therapy, extracorporeal shockwave therapy
- Surgical treatment, including resection of inferior or calcaneal exostosis with plantar fasciotomy, plantar fasciotomy as an isolated procedure, calcaneal decompression, tendon lengthening/tenotomy/capsulotomy, autologous fat transfer
- Postoperative management, including radiographs, follow-up visits, weight bearing/immobilization, and orthotics
Major Outcomes Considered
|
Methods Used to Collect/Select the Evidence
Searches of Electronic Databases
Description of Methods Used to Collect/Select the Evidence
The guideline development process began with a thorough MEDLINE search as well as a "call for papers" from the membership of the Academy of Ambulatory Foot and Ankle Surgery at large.
Number of Source Documents
Methods Used to Assess the Quality and Strength of the Evidence
Not stated
Rating Scheme for the Strength of the Evidence
Methods Used to Analyze the Evidence
Review
Description of the Methods Used to Analyze the Evidence
Methods Used to Formulate the Recommendations
Not stated
Rating Scheme for the Strength of the Recommendations
Cost Analysis
A formal cost analysis was not performed and published cost analyses were not reviewed.
Method of Guideline Validation
Internal Peer Review
Description of Method of Guideline Validation
Drafts of the guidelines were reviewed in detail by each member of the Board of Trustees.
|
Major Recommendations
- Diagnosis
- History may include any of the following:
- An evaluation of the chief complaint (including nature, location, duration, onset, course, anything that improves or exacerbates, and any previous treatment).
- The past medical history (including allergies/medications, medical history, surgical history, family history, and social history).
- Physical examination may include:
- Peripheral vascular
- Neurological
- Orthopedic
- Palpation (direct/lateral pressure)
- Biomechanical/gait analysis
- Range of motion
- Diagnostic Procedures
- Radiographic examination: X-rays should be taken. They are necessary to confirm/rule out bony pathology. X-rays may be weight bearing, partial weight bearing, or non weight bearing.
- Laboratory tests: Used to rule out inflammatory disease, infection, degenerative joint disease, systemic illness, etc.
- Additional tests (nerve conduction studies, electromyography [EMG], noninvasive vascular testing): These studies may be utilized in isolated situations when deemed necessary.
- Differential diagnosis may include:
- Plantar fasciitis without spur formation
- Bursitis (inferior or retrocalcaneal)
- Tendonitis
- Osteochondritis
- Periostitis
- Arthritis
- Fracture
- Neoplasms (malignant/benign)
- Neuritis
- Tarsal tunnel syndrome
- Neuroma
- Peripheral neuropathy
- Herniation of the plantar fat pad
- Haglund's deformity
- Infection (i.e., osteomyelitis, soft tissue)
- Gout
- Reflex sympathetic dystrophy
- Vascular insufficiency
- Systemic illness
- Medication induced (i.e., patients on thiazide diuretics)
- Nonsurgical Treatment
- Goals of treatment:
Conservative (nonsurgical) treatment is primarily geared to relieving symptomatology. In most cases, conservative care should be considered prior to surgery.
- Types of treatment:
- Padding and strapping (taping)
- Orthotics
- Heel cup
- Shoe modifications
- Oral anti-inflammatory medications (NSAIDs)
- Anti-inflammatory injectables (i.e., corticosteroids)
- Injection of local anesthetics (i.e., peripheral nerve block)
- Analgesics
- Physical therapy
- Extracorporeal shockwave therapy
- Surgical Treatment
- Goals of treatment:
The goal of surgical treatment is not only to relieve the symptom(s), but to correct the underlying deformities and to improve function as well.
- The primary reasons for surgical treatment are:
- Failure of nonsurgical treatment
- Impracticality of nonsurgical treatment
- The patient desires correction of a presenting deformity that is painful and/or causes a degree of loss of function
- The patient is informed of the procedure(s) to be performed, the treatment alternatives, and the reasonable risks involved, and elects to have surgical intervention
- Site of surgery:
The surgical treatment of heel spur syndrome may be performed in the doctor's office. The hospital or an ambulatory surgical center may also be appropriate.
- Anesthesia:
Local anesthesia is sufficient, unless there are extenuating circumstances. Intravenous (I.V.) sedation may be utilized with this.
- Hemostasis:
Absence of bleeding is not required via tourniquet, but may be utilized at the discretion of the surgeon.
- Surgical preparation:
Aseptic preparation ("usual" aseptic scrub, prep, draping and sterile technique)
- Preoperative lab:
Necessity based upon patient's past medical history and current medical status
- Prophylactic antibiotics:
At the discretion of the surgeon (or based upon requirement: i.e., mitral valve prolapse)
- Pathological analysis of surgically removed tissue is recommended.
- Bilateral or multiple surgeries may be performed either at the same session or in different surgical sessions.
- Second opinion:
At the option of the patient or doctor
- Surgical Procedures for the Treatment of Heel Spur Syndrome
These may include one or more of the following:
- Resection of inferior or calcaneal exostosis with plantar fasciotomy
- Plantar fasciotomy as an isolated procedure (i.e., endoscopic, minimally invasive surgery [MIS], or traditional approaches)
- Calcaneal decompression
- Tendon lengthening/tenotomy/capsulotomy may be used for heel spur syndrome in the event that the purpose of these procedures is both for treatment of the heel spur syndrome and the "hammertoe syndrome" as well.
- Autologous fat transfer
- Postoperative Management
- Radiographs: Should be taken immediately following surgery if osseous surgery has been performed. Additional x-rays as needed.
- Postoperative visits: In the absence of complications, the patient should initially be seen within the first week following the procedure(s). Subsequent visits are determined by the procedures performed and the postoperative course.
- Weight bearing/immobilization: Based upon the procedures performed and upon the individual patient, full, partial, or non-weight bearing may be utilized. Generally, a surgical dressing is applied in the immediate postoperative period. This is modified with time and the postoperative course. A postoperative shoe is usually indicated. Casting may or may not be necessary. The return to normal shoe is based upon the procedure(s) performed and the postoperative course of the individual patient.
- Orthotics: May be prescribed to improve biomechanics.
|
Evidence Supporting the Recommendations
Type of Evidence Supporting the Recommendations
The type of supporting evidence is not specifically stated for each recommendation.
|
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
Treatment may relieve or reduce pain, reduce the deformity, improve function, and arrest the progression of the deformity.
Potential Harms
Postoperative Complications
- Numbness
- Edema
- Pain
- Recurrence
- Hematoma
- Infection
- Painful and/or hypertrophic scar formation
- Adhesions
- Vascular complications
- Reflex sympathetic dystrophy
- Fracture
- Gangrene
- Tissue necrosis
|
Implementation of the Guideline
Description of Implementation Strategy
An implementation strategy was not provided.
|
Institute of Medicine (IOM) National Healthcare Quality Report Categories
IOM Care Need
Getting Better
Living with Illness
IOM Domain
Effectiveness
Patient-centeredness
|
Identifying Information and Availability
Bibliographic Source(s)
Academy of Ambulatory Foot and Ankle Surgery. Heel spur syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2003. 6 p. [14 references] |
Adaptation
Not applicable: The guideline was not adapted from another source.
Date Released
2000 (revised 2003 Sep; reviewed 2009 Sep)
Guideline Developer(s)
Academy of Ambulatory Foot and Ankle Surgery - Medical Specialty Society
Source(s) of Funding
Academy of Ambulatory Foot and Ankle Surgery (AAFAS)
Guideline Committee
Preferred Practice Guidelines Committee
Composition of Group That Authored the Guideline
The committee consisted of five (5) members who were board certified, had a minimum of ten (10) years of clinical practice experience, and a minimum of five (5) years of teaching experience.
Financial Disclosures/Conflicts of Interest
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Academy of Ambulatory Foot and Ankle Surgery. Heel spur syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 12 p.
The guideline is reviewed and updated twice a year as needed (in May and October). According to the guideline developer, this guideline has been reviewed and is still considered current as of September 2009. This review involved new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.
Guideline Availability
Electronic copies: Not available at this time.
Print copies: Available from the Academy of Ambulatory Foot and Ankle Surgery (AAFAS) (formerly the Academy of Ambulatory Foot Surgery), 1601 Walnut Street, Suite 1005, Philadelphia, PA 19102; Web site, www.academy-afs.org .
Availability of Companion Documents
NGC Status
This summary was completed by ECRI on October 12, 2000. The information was verified by the guideline developer as of December 8, 2000. This summary was updated by ECRI on December 19, 2003. The information was verified by the guideline developer on December 29, 2003. This summary was updated on May 3, 2005 following the withdrawal of Bextra (valdecoxib) from the market and the release of heightened warnings for Celebrex (celecoxib) and other nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). This summary was updated by ECRI on June 16, 2005, following the U.S. Food and Drug Administration advisory on COX-2 selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs).
Copyright Statement
This NGC summary is based on the original guideline, which is copyrighted by the guideline developer.
|
NGC Disclaimer
The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site. Read full disclaimer...The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.
All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.
Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx.
NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.
Readers with questions regarding guideline content are directed to contact the guideline developer. Hide...
|